Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenarians


      Previous studies demonstrated a relationship between the degree of insulin resistance and plasma plasminogen activator inhibitor type-1 (PAI-1) levels. We aim at investigating the relationship between the degree of insulin resistance and plasma PAI-1 levels in aged subjects (n=83) and in healthy centenarians (n=42). In all subjects the degree of insulin resistance was assessed by HOMA method. Our data demonstrated that healthy centenarians have higher plasma PAI-1 levels (73.1±13.9 vs 23.7±14.7 ng/ml, P<0.001) and lower degree of insulin resistance (1.4±0.5 vs 3.3±1.3, P<0.001) than aged subjects. In aged subjects plasma PAI-1 levels correlated with the degree of insulin resistance (r=0.61, P<0.001), fasting plasma triglycerides (r=0.74, P<0.001) and age (r=0.33, P<0.001). All such associations were lost in centenarians. Plasma PAI-1 Ag levels were also similar in aged subjects and centenarians even after categorization for PAI gene polymorphism. In multivariate analysis, a model made by age, sex, body mass index, fasting plasma triglycerides, HOMA and PAI-1 gene explained 65 and 50% of plasma PAI-1 level variations in aged subjects and centenarians, respectively. Nevertheless, HOMA (P<0.001) was significantly and independently associated with plasma PAI-1 levels only in aged subjects. In conclusion, our data demonstrates that in healthy centenarians, plasma PAI-1 were not associated with the degree of insulin resistance as in aged subjects. Frequency of PAI-1 genotype does not provide an explanation for such differences between aged subjects and centenarians.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ernst E.
        • Resch K.L.
        Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature.
        Ann Intern Med. 1993; 118: 956-963
        • Meade T.W.
        • Mellows S.
        • Brozovic M.
        • Miller G.J.
        • Chakrabarti R.R.
        • North W.R.S.
        • et al.
        Haemostatic function and ischemic heart disease: principal results of the Northwick Park Study.
        Lancet. 1986; 2: 533-537
        • Ridker P.M.
        • Vaughan D.E.
        • Stamptfer M.J.
        • Manson J.E.
        • Hennekes C.H.
        Endogenous tissue-type plasminogen activator and risk of myocardial infarction.
        Lancet. 1993; 341: 1165-1168
        • Hamsten A.
        • De Faire U.
        • Walldius G.
        • Dahlen G.
        • Szamosi A.
        • Landou C.
        • et al.
        Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.
        Lancet. 1987; 2: 3-9
        • Di Minno G.
        • Mancini F.P.
        • Margaglione M.
        Haemostatic variables and ischemic cardiovascular disease: do we need a concerted effort for more profitable future clinical investigation?.
        Cardiovasc Drugs Ther. 1996; 10: 743-749
        • Ridker P.M.
        • Hennekes C.H.
        • Stamptfer M.J.
        • Manson J.E.
        • Vaughan D.E.
        Prospective study of endogenous tissue plasminogen activator and risk of stroke.
        Lancet. 1994; 343: 940-943
        • Mansfield M.W.
        • Stickland M.H.
        • Grant P.J.
        Environmental and genetic factors in relation to elevated circulating levels plasminogen activator inhibitor-1 in Caucasian patients with non insulin dependent diabetes mellitus.
        Thromb Haemost. 1995; 74: 842-847
        • Bastard J.P.
        • Peironi L.
        • Hainque B.
        Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance.
        Diabetes Metab Res Rev. 2000; 16: 192-201
        • Meigs J.B.
        • Mittleman M.A.
        • Nathan D.M.
        • Tofler G.H.
        • Singer D.E.
        • Murphy-Sheely P.M.
        • et al.
        Hyperinsulinemia, hyperglycemia and impaired hemostasis: the Framingham Offspring Study.
        JAMA. 2000; 283: 221-228
        • Landin K.
        • Stigendal L.
        • Eriksson E.
        • Krotkiewski M.
        • Risberg B.
        • Tengborn L.
        • et al.
        Abdominal obesity is associated with impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.
        Metabolism. 1990; 39: 1044-1048
        • Asplund-Carlson A.
        • Hamsten A.
        • Wiman B.
        • Carlson L.A.
        Relationship between plasma plasminogen activator inhibitor – 1 activity and VLDL triglyceride concentration, insulin levels and sensitivity: studies randomly selected normo- and hypertriglyceridaemic med.
        Diabetologia. 1993; 36: 817-825
        • Festa A.
        • D'Agostino R.
        • Mykkanen L.
        • Tracy L.
        • Howard B.V.
        • Haffner S.M.
        Low density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study.
        Arterioscler Thromb Vasc Biol. 1999; 19: 605-610
        • Paolisso G.
        • Tagliamonte M.R.
        • Rizzo M.R.
        • Giugliano D.
        Advancing age and insulin resistance: new facts about an ancient history.
        Eur J Clin Invest. 1999; 29: 758-769
        • Javorschi S.
        • Richard-Harston S.
        • Labrouche S.
        • Manciet G.
        • Freyburger G.
        Relative influence of age and thrombotic history on hemostatic parameters.
        Thromb Res. 1998; 91: 241-248
        • Byberg L.
        • Siegbahn A.
        • Berglund L.
        • McKeigue P.
        • Reneland R.
        • Lithell H.
        Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-years old men.
        Arterioscler Thromb Vasc Biol. 1998; 18: 258-264
        • Paolisso G.
        • Gambardella A.
        • Balbi V.
        • Ammendola S.
        • D'Amore A.
        • Varricchio G.
        Body composition, body fat distribution and resting metabolic rate in healthy centenarians.
        Am J Clin Nutr. 1995; 62: 746-750
        • Shaw J.E.
        • McCarty D.
        • Zimmet P.
        • De Courten M.
        Type 2 diabetes worldwide according to the new classification and criteria.
        Diab Care. 2000; 23: B5-B10
        • Matthews D.R.
        • Hosker J.P.
        • Rudenski A.S.
        • Naylor B.A.
        • Treacher D.F.
        • Turner R.C.
        Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man.
        Diabetologia. 1985; 28: 412-419
        • Bonora E.
        • Targher G.
        • Alberiche M.
        • Bonadonna R.
        • Saggiani F.
        • Zenere M.B.
        • et al.
        Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Study in subjects with various degree of glucose tolerance and insulin sensitivity.
        Diab Care. 2000; 23: 57-63
        • Margaglione M.
        • Cappucci G.
        • D'Addedda M.
        • Colaizzo D.
        • Giuliani N.
        • Vecchione G.
        • et al.
        PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants.
        Arterioscler Thromb Vascu Biol. 1998; 18: 562-567
        • Potter van Loon B.J.
        • Kluft C.
        • Radder J.K.
        • Blankenstein M.A.
        • Mienders A.E.
        The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.
        Metabolism. 1993; 42: 945-949
        • Paolisso G.
        • Tagliamonte M.R.
        • Rizzo M.R.
        • Rotondi M.
        • Gualdiero P.
        • Gambardella A.
        • et al.
        Mean arterial blood pressure and serum levels of the molar ratio of insulin-like growth factor-1 to its binding protein-3 in healthy centenarians.
        J Hypertension. 1999; 17: 67-73
        • Paolisso G.
        • Gambardella A.
        • Ammendola S.
        • Tagliamonte M.R.
        • Rizzo M.R.
        • Capurso A.
        • et al.
        Preserved antilipolytic insulin action is associated with a less atherogenic plasma lipid profile in healthy centenarians.
        J Am Geriatr Soc. 1997; 45: 1504-1509
        • Paolisso G.
        • Gambardella A.
        • Ammendola S.
        • D'Amore A.
        • Balbi V.
        • Varricchio M.
        • et al.
        Glucose tolerance and insulin action in healthy centenarians.
        Am J Physiol. 1996; 270: E890-894
        • Paolisso G.
        • Barbieri M.
        • Bonafè M.
        • Franceschi C.
        Metabolic age remodelling: the lesson from centenarians.
        Eur J Clin Invest. 2000; 30: 888-894
        • Gurlek A.
        • Bayraktar M.
        • Kirazli S.
        Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients. Lack of association with plasma insulin levels.
        Diab Care. 2000; 23: 88-92
        • Alessi M.C.
        • Juhan-Vague I.
        • Kooistra T.
        • Declerck P.J.
        • Collen D.
        Insulin stimulates the synthesis of plasminogen activator inhibitor by human hepatocelluar cell line Hep G2.
        Thromb Haemost. 1988; 60: 491-494
        • Nordt T.K.
        • Schneider D.J.
        • Sobel B.E.
        Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursor of insulin.
        Circulation. 1994; 89: 321-330
        • Eliasson M.
        • Roder M.E.
        • Dinesen B.
        • Evrin P.E.
        • Lindhal B.
        Proinsulin, intact insulin and fibrinolytic variables and fibrinogen in healthy subjects: a population study.
        Diab Care. 1997; 20: 1252-1255
        • Festa A.
        • D'Agostino Jr, R.
        • Mykkanen L.
        • Tracy R.P.
        • Zaccaro D.J.
        • Hales C.N.
        • et al.
        Relative contribution of insulin and its precursor to fibrinogen and PAI-1 in a large population with different states of glucose tolerance: the Insulin Resistance Atherosclerosis Study.
        Arterioscler Thromb Vasc Biol. 1999; 19: 562-568
        • Landin K.
        • Tengborn L.
        • Chmielewska J.
        • Von Schenck H.
        • Smith U.
        The acute effect of insulin on tissue plasminogen activator inhibitor in man.
        Thromb Haemost. 1991; 65: 130-133
        • Grant P.J.
        • Kruithof E.K.O.
        • Felley C.P.
        • Felber J.P.
        • Bachmann F.
        Short term infusion of insulin, triacylglycerol and glucose do not cause acute increase in plasminogen actiavtor-1 concentrations in man.
        Clin Sci. 1990; 79: 513-516
        • Vuorinen-Markkola H.
        • Puhakainen I.
        • Yki-Jarvinen H.
        No evidence for short-term regulation of plasminogen activator inhibitor activity by insulin in man.
        Thromb Haemost. 1992; 67: 117-120
        • Mari D.
        • Mannucci P.M.
        • Coppola R.
        • Bottasso B.
        • Bauer K.A.
        • Rosenberg R.D.
        Hypercoagulabity in centenarians: the paradox of successful aging.
        Blood. 1995; 85: 3144-3149
        • Bladbjerg E.M.
        • Andersen Ranberg K.
        • De Maat M.P.
        • Kristensen S.R.
        • Jeune B.
        • Gram J.
        • et al.
        Longevity is independent of common variation in genes associated with cardiovascular risk.
        Thromb Haemost. 1999; 82: 1100-1105
        • Mannucci P.M.
        • Mari D.
        • Peyvandi L.
        • Tagliabue E.
        • Sacchi E.
        • Taioli E.
        • et al.
        Gene polymophisms predicting high plasma levels of coagulation and fibrinolysis. A study in centenarians.
        Arterioscler Thromb Vasc Biol. 1997; 17: 755-759